EasySep™小鼠TIL（CD45）正选试剂盒
产品号 #72722_C
视黄醇通路激活剂；激活视黄酸受体（RAR）
若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系
总览
CD437是视黄醇相关分子家族中典型的金刚烷芳香视黄酸类化合物，作为视黄酸受体(RAR)γ的选择性激活剂（RAR α、β和γ的Kd分别为6.5µM、2.5µM和77 nM）。（Bernard et al.; Pérez-Rodríguez et al.)。
重编程
·可加快并增加从转染了 Oct4、Sox2、c-Myc 和 Klf4 的小鼠胚胎成纤维细胞（MEFs）中生成的预诱导多能干（iPS）细胞集落的数量（Wang et al.）。
癌症研究
·诱导多种癌细胞的细胞周期阻滞和凋亡(Fontana and Rishi; Jin et al.; Li et al.; Valli et al.)
·降低人头颈鳞状细胞癌细胞系UMSCC22B中鳞状分化标志物——细胞角蛋白1（ cytokeratin 1）、involucrin和SPR1的mRNA表达（Sun et al.）。
细胞类型
癌细胞及细胞系，多能干细胞
种属
人，小鼠，非人灵长类，其它细胞系，大鼠
应用
重编程
研究领域
癌症，干细胞生物学
CAS 编号
125316-60-1
化学式
C₂₇H₂₆O₃
纯度
≥ 95 %
通路
视黄醇类
靶点
RAR
产品说明书及文档
请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。
应用领域
本产品专为以下研究领域设计，适用于工作流程中的高亮阶段。探索这些工作流程，了解更多我们为各研究领域提供的其他配套产品。
相关材料与文献
技术资料 (3)
文献 (8)
Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proceedings of the National Academy of Sciences of the United States of America 2011 NOV
Abstract
Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) by expressing four transcription factors: Oct4, Sox2, Klf4, and c-Myc. Here we report that enhancing RA signaling by expressing RA receptors (RARs) or by RA agonists profoundly promoted reprogramming, but inhibiting it using a RAR-α dominant-negative form completely blocked it. Coexpressing Rarg (RAR-γ) and Lrh-1 (liver receptor homologue 1; Nr5a2) with the four factors greatly accelerated reprogramming so that reprogramming of mouse embryonic fibroblast cells to ground-state iPSCs requires only 4 d induction of these six factors. The six-factor combination readily reprogrammed primary human neonatal and adult fibroblast cells to exogenous factor-independent iPSCs, which resembled ground-state mouse ES cells in growth properties, gene expression, and signaling dependency. Our findings demonstrate that signaling through RARs has critical roles in molecular reprogramming and that the synergistic interaction between Rarg and Lrh1 directs reprogramming toward ground-state pluripotency. The human iPSCs described here should facilitate functional analysis of the human genome.
Highly twisted adamantyl arotinoids: synthesis, antiproliferative effects and RXR transactivation profiles. European journal of medicinal chemistry 2009 JUN
Abstract
Retinoid-related molecules with an adamantyl group (adamantyl arotinoids) have been described with selective activities towards the retinoid receptors as agonists for NR1B2 and NR1B3 (RARbeta,gamma) (CD437, MX3350-1) or RAR antagonists (MX781) that induce growth arrest and apoptosis in cancer cells. Since these molecules induce apoptosis independently of RAR transactivation, we set up to synthesize novel analogs with impaired RAR binding. Here we describe adamantyl arotinoids with 2,2'-disubstituted biaryl rings prepared using the Suzuki coupling of the corresponding fragments. Those with cinnamic and naphthoic acid end groups showed significant antiproliferative activity in several cancer cell lines, and this effect correlated with the induction of apoptosis as measured by caspase activity. Strikingly, some of these compounds, whereas devoid of RAR binding capacity, were able to activate RXR.
Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity. Molecular cancer therapeutics 2008 SEP
Abstract
Retinoid-related molecules (RRM) are novel agents with tumor-selective cytotoxic/antiproliferative activity, a different mechanism of action from classic retinoids and no cross-resistance with other chemotherapeutics. ST1926 and CD437 are prototypic RRMs, with the former currently undergoing phase I clinical trials. We show here that ST1926, CD437, and active congeners cause DNA damage. Cellular and subcellular COMET assays, H2AX phosphorylation (gamma-H2AX), and scoring of chromosome aberrations indicate that active RRMs produce DNA double-strand breaks (DSB) and chromosomal lesions in NB4, an acute myeloid leukemia (AML) cell line characterized by high sensitivity to RRMs. There is a direct quantitative correlation between the levels of DSBs and the cytotoxic/antiproliferative effects induced by RRMs. NB4.437r blasts, which are selectively resistant to RRMs, do not show any sign of DNA damage after treatment with ST1926, CD437, and analogues. DNA damage is the major mechanism underlying the antileukemic activity of RRMs in NB4 and other AML cell lines. In accordance with the S-phase specificity of the cytotoxic and antiproliferative responses of AML cells to RRMs, increases in DSBs are maximal during the S phase of the cell cycle. Induction of DSBs precedes inhibition of DNA replication and is associated with rapid activation of ataxia telangectasia mutated, ataxia telangectasia RAD3-related, and DNA-dependent protein kinases with subsequent stimulation of the p38 mitogen-activated protein kinase. Inhibition of ataxia telangectasia mutated and DNA-dependent protein kinases reduces phosphorylation of H2AX. Cells defective for homologous recombination are particularly sensitive to ST1926, indicating that this process is important for the protection of cells from the RRM-dependent DNA damage and cytotoxicity.
更多信息
| 种属 | Human, Mouse, Non-Human Primate, Other, Rat |
|---|---|
| Cas Number | 125316-60-1 |
| Chemical Formula | C₂₇H₂₆O₃ |
| 纯度 | ≥ 95% |
| Target | RAR |
| Pathway | Retinoid |
相关产品
-
ReproRNA™-OKSGM一种非整合型、自我复制的 RNA 重编程载体，用于生成诱导多能干细胞
-
丙戊酸（钠盐）表观遗传修饰剂；抑制组蛋白去乙酰化酶 (HDAC)1
-
RepSox（盐酸盐）激活素/BMP/TGF-β通路抑制剂；抑制ALK5
